All In Biotech

Drug Trial Radar · NCT03308799

A Clinical Trial Evaluating Efficacy and Safety of MC2-01 Cream

A Randomised, Multicentre, Investigator-Blind, Parallel-Group Trial to Evaluate the Efficacy and Safety of MC2-01 Cream Compared to Vehicle and Active Comparator in Subjects With Mild-to-Moderate Psoriasis Vulgaris

Last checked: Nov 19, 2026Latest source record: Dec 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 794 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

794

Actual

Start

Oct 3, 2017

Primary completion

Jun 8, 2018

Study completion Jun 8, 2018

Sponsor

Lead sponsor
MC2 TherapeuticsIndustry
Sponsor type
Industry
First posted
Oct 13, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial is a randomized, investigator-blind, multicentre, vehicle- and comparator-controlled, parallel-group trial with the purpose of evaluating efficacy, safety and convenience of the MC2-01 cream.

Conditions

  • Psoriasis Vulgaris

Interventions

  • MC2-01 creamDrug

    MC2-01 (calcipotriene/betamethasone dipropionate, w/w 0.005%/0.064%) cream

  • Cal/BDP combinationDrug

    calcipotriene/betamethasone dipropionate, w/w 0.005%/0.064%

  • Cream vehicleDrug

    Vehicle Cream

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With a Decrease in the Physicians Global Assessment (PGA) Score of Minimum 2 Points on a Scale From 0-4 From Baseline to Week 8Time frame: Baseline and 8 weeks

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Henry Ford Hospital

    Detroit, Michigan

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • Richard Herdener, MD

    Spokane, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.